122 related articles for article (PubMed ID: 38809542)
61. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
[TBL] [Abstract][Full Text] [Related]
62. Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma.
Klatte DCF; Starr JS; Clift KE; Hardway HD; van Hooft JE; van Leerdam ME; Potjer TP; Presutti RJ; Riegert-Johnson DL; Wallace MB; Bi Y
JCO Oncol Pract; 2024 Apr; ():OP2300447. PubMed ID: 38621197
[TBL] [Abstract][Full Text] [Related]
63. Prevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan.
Alvarado M; Tiller GE; Chung J; Haque R
J Community Genet; 2020 Jul; 11(3):359-366. PubMed ID: 32096056
[TBL] [Abstract][Full Text] [Related]
64. Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in
Llach J; Aguilera P; Sánchez A; Ginès A; Fernández-Esparrach G; Soy G; Sendino O; Vaquero E; Carballal S; Ausania F; Ayuso JR; Darnell A; Pellisé M; Castellví-Bel S; Puig S; Balaguer F; Moreira L
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980574
[TBL] [Abstract][Full Text] [Related]
65. THE ADDED VALUE OF BLOOD GLUCOSE MONITORING IN HIGH-RISK INDIVIDUALS UNDERGOING PANCREATIC CANCER SURVEILLANCE.
Bogdanski AM; Onnekink AM; Inderson A; Boekestijn B; Bonsing BA; Vasen HFA; van Hooft JE; Boonstra JJ; Mieog JSD; Wasser MNJM; Feshtali S; Potjer TP; Klatte DCF; van Leerdam ME
Pancreas; 2024 Apr; ():. PubMed ID: 38598368
[TBL] [Abstract][Full Text] [Related]
66. PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients.
Siraj AK; Bu R; Parvathareddy SK; Iqbal K; Azam S; Qadri Z; Al-Rasheed M; Haqawi W; Diaz M; Victoria IG; Al-Badawi IA; Tulbah A; Al-Dayel F; Ajarim D; Al-Kuraya KS
Sci Rep; 2023 May; 13(1):7666. PubMed ID: 37169825
[TBL] [Abstract][Full Text] [Related]
67. Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome.
Kim J; Braun D; Ukaegbu C; Dhingra TG; Kastrinos F; Parmigiani G; Syngal S; Yurgelun MB
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):830-837.e1. PubMed ID: 31319185
[TBL] [Abstract][Full Text] [Related]
68. Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes.
Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Katz SJ
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426465
[TBL] [Abstract][Full Text] [Related]
69. Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions.
Su Y; Yao Q; Xu Y; Yu C; Zhang J; Wang Q; Li J; Shi D; Yu B; Zeng Y; Zhu X; Bai Q; Zhou X
Front Genet; 2021; 12():674094. PubMed ID: 34917121
[No Abstract] [Full Text] [Related]
70. Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.
Ložar T; Žgajnar J; Perhavec A; Blatnik A; Novaković S; Krajc M
Eur J Surg Oncol; 2021 Aug; 47(8):1900-1906. PubMed ID: 33812767
[TBL] [Abstract][Full Text] [Related]
71. PALB2 germline mutations in a multi-gene panel testing cohort of 1905 breast-ovarian cancer patients in Argentina.
Gonzalez A; Del Greco F; Vargas-Roig L; Brun B; Tabares G; Mampel A; Montes C; Martin C; Lopez M; Rossi N; Bruno L; Ponce C; Quaglio P; Yanzi A; Acevedo S; Lugo L; Lopez Breccia P; Avila S; Sisterna S; Del Castillo MS; Vazquez M; Nuñez LM
Breast Cancer Res Treat; 2022 Jul; 194(2):403-412. PubMed ID: 35610400
[TBL] [Abstract][Full Text] [Related]
72. Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes.
Kurian AW; Abrahamse P; Ward KC; Hamilton AS; Deapen D; Berek JS; Hoang L; Yussuf A; Dolinsky J; Brown K; Slavin T; Hofer TP; Katz SJ
JCO Precis Oncol; 2021; 5():. PubMed ID: 34977446
[TBL] [Abstract][Full Text] [Related]
73. CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome.
Cremin C; Howard S; Le L; Karsan A; Schaeffer DF; Renouf D; Schrader KA
Hered Cancer Clin Pract; 2018; 16():7. PubMed ID: 29541281
[TBL] [Abstract][Full Text] [Related]
74. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
Hu C; Hart SN; Bamlet WR; Moore RM; Nandakumar K; Eckloff BW; Lee YK; Petersen GM; McWilliams RR; Couch FJ
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):207-11. PubMed ID: 26483394
[TBL] [Abstract][Full Text] [Related]
75. Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma.
Yadav S; Kasi PM; Bamlet WR; Ho TP; Polley EC; Hu C; Hart SN; Rabe KG; Boddicker NJ; Gnanaolivu RD; Lee KY; Lindstrom TH; Petersen GM; Couch FJ; McWilliams RR
Clin Cancer Res; 2020 Dec; 26(24):6505-6512. PubMed ID: 33028596
[TBL] [Abstract][Full Text] [Related]
76. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
77. Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer.
Golan T; Sella T; O'Reilly EM; Katz MH; Epelbaum R; Kelsen DP; Borgida A; Maynard H; Kindler H; Friedmen E; Javle M; Gallinger S
Br J Cancer; 2017 Mar; 116(6):697-702. PubMed ID: 28183138
[TBL] [Abstract][Full Text] [Related]
78. Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.
Chittenden A; Haraldsdottir S; Ukaegbu C; Underhill-Blazey M; Gaonkar S; Uno H; Brais LK; Perez K; Wolpin BM; Syngal S; Yurgelun MB
JCO Oncol Pract; 2021 Feb; 17(2):e236-e247. PubMed ID: 33439686
[TBL] [Abstract][Full Text] [Related]
79. Mutational profile of hereditary breast and ovarian cancer - Establishing genetic testing guidelines in a developing country.
Krivokuca A; Mihajlovic M; Susnjar S; Spasojevic IB; Minic I; Popovic L; Brankovic-Magic M
Curr Probl Cancer; 2022 Feb; 46(1):100767. PubMed ID: 34284872
[TBL] [Abstract][Full Text] [Related]
80. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]